Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2987277 | The Journal of Thoracic and Cardiovascular Surgery | 2006 | 9 Pages |
Abstract
The risk of mortality during aortic valve surgery is due mostly to active endocarditis, New York Heart Association class, and comorbidity. We failed to find a significant effect of reoperation on perioperative mortality. Mechanical valves, with their attendant anticoagulation-related morbidity, should not be implanted solely because of anticipated high mortality associated with bioprosthetic rereplacement.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Piroze M. MD, Michael A. MD, PhD, Tirone E. MD, Vivek MD, PhD, Manjula MSc, Terrence M. MD, MSc,